Search – Page 6 – Indianapolis Business Journal

Home » Search

Articles

Former GLP-1 users regain lost weight after about 18 months, study says

January 8, 2026 | The Washington Post

People who stop taking GLP-1 drugs such as Ozempic, Wegovy and Zepbound for weight loss are projected to regain their shed pounds within about 1-½ years, a review of existing research has found.

Pharmaceutical company planning to employ 300 workers in Greenfield

January 8, 2026 | Daniel Bradley

The plant will focus on serving health care companies by developing and commercializing medical devices, drug delivery systems and combination products.

Lilly to acquire California-based biopharma company in $1.2B deal

January 7, 2026 | Holly Hays

Indianapolis-based Eli Lilly and Co. announced Wednesday it intends to acquire Ventyx Biosciences, a clinical-stage biopharmaceutical company developing oral therapies for inflammatory-mediated diseases.

Lilly in talks to buy Ventyx Biosciences for more than $1B, WSJ reports

January 7, 2026 | Bloomberg News and IBJ Staff

Ventyx is a San Diego-based biotech that specializes in drugs for inflammatory diseases like Crohn’s and rheumatoid arthritis.

Eli Lilly set to back Aktis Oncology’s upsized $318M IPO

January 7, 2026 | Bloomberg News

Clinical-stage biotechnology company Aktis Oncology increased the size of its initial public offering by 50% and drew interest from Indianapolis-based Lilly for $100 million of shares in the listing.

First GLP-1 weight-loss pill now available, with pledge of abundant supply

January 6, 2026 | The Washington Post

Novo Nordisk is aiming to avoid losing ground to its main rival, Eli Lilly, which is seeking regulatory approval for its own GLP-1 weight-loss pill.

Partnership between public affairs firms highlights growing Indiana-Ireland bond

January 5, 2026 | Marek Mazurek

A former Hoosier lawmaker and a former Irish government minister are linking their firms as Indiana’s ties to Ireland grow.

Indiana attorney general sues Lilly over insulin prices

January 5, 2026 | Daniel Lee

Attorney General Todd Rokita said the lawsuit, filed last Wednesday in the Lake County Superior Court, is part of his office’s intensifying efforts to lower insulin prices and improve health care affordability.

Mitch Frazier: One Health holds promise for Indiana and the world

January 2, 2026 | Mitch Frazier

While no single solution exists to overcome America’s health woes, the next wave of breakthroughs could emerge at the intersection of farms, feed lots, food and pharmaceuticals.

2025 Newsmaker: Jeff Simmons

December 26, 2025

Jeff Simmons has been CEO of Elanco since its spinoff from Eli Lilly and Co. in 2018, guided the company’s 2020 acquisition of Bayer Animal Health and has overseen the development of drugs that are starting to pay off in profits and investor confidence.

2025 Newsmaker: David Ricks

December 26, 2025 | IBJ Staff

As of Nov. 13, Eli Lilly and Co.’s market capitalization was $967 billion and flirting with a rare $1 trillion. Its stock price in November surpassed $1,000 per share, up more than 25% for the year.

US regulators approve Wegovy pill for weight loss, giving Novo Nordisk an edge over Lilly

December 22, 2025 | Associated Press

Novo Nordisk’s Wegovy pills are expected to be available within weeks, while Indianapolis-based Eli Lilly and Co. waits for approval for its daily GLP-1 pill, orforglipron.

Republicans and Democrats pitch competing plans to tackle affordability

December 22, 2025 | The Washington Post

Lawmakers in both parties view simmering fury over the cost of living as the top issue in next year’s midterm elections and are pitching a growing profusion of proposals to tackle the notoriously difficult problem of affordability.

Lilly’s growth explosion tests state’s workforce development

December 19, 2025 | Daniel Lee

Eli Lilly and Co.’s career website this month listed 254 job openings in Indianapolis and another 90 in Lebanon, accounting for more than three-quarters of the 445 open positions the pharmaceutical giant listed across the United States.

Lilly Phase 3 trial shows GLP-1 pill effective for weight-loss maintenance

December 18, 2025 | Daniel Lee

According to the study, orforglipron users maintained their weight loss levels more closely after previously taking a rival’s GLP-1 injectable, the Indianapolis-based drugmaker said.

State health insurance plan changes reflect Braun’s vision

December 12, 2025 | Daniel Lee

For 2026, the plan features significantly lower out-of-pocket costs for members who use the plan’s “narrow network” that limits choice.

Citizens Energy ready to start work on Lebanon water project

December 12, 2025 | Daniel Bradley

Construction is set to begin early next year on a $560 million project to send millions of gallons of water each day to Lebanon to meet the demands of the state’s 9,000-acre LEAP Research and Innovation District.

Claire Fiddian-Green: Navigating AI’s impact, personally and professionally

December 12, 2025 | Claire Fiddian-Green

The good news is that Indiana is an early adopter of AI tools in K-12 education.

Lilly to build $6B plant in Alabama in 3rd of 4 big US investments

December 9, 2025 | Daniel Lee

Lilly’s planned Huntsville site is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 billion reshoring investment unveiled early this year.

Editorial: Proposed congressional districts hurt anchor of state’s economy

December 5, 2025

Indianapolis voters need the ability to send a representative to Congress who will advocate for the city, its people and the many corporate headquarters—Eli Lilly and Co., Elevance Health, Roche Diagnostics, Corteva, Simon Property Group and others—located here.

« Previous 1 … 4 5 6 7 8 … 12 Next »

Search Results

237 results for '\"eli lilly\"'